Browse > Article
http://dx.doi.org/10.14348/molcells.2016.0243

Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells  

Nguyen, Linh Thi Thao (Faculty of Biotechnology, College of Applied Life Sciences, SARI)
Song, Yeon Woo (Faculty of Biotechnology, College of Applied Life Sciences, SARI)
Cho, Somi Kim (Faculty of Biotechnology, College of Applied Life Sciences, SARI)
Publication Information
Molecules and Cells / v.39, no.12, 2016 , pp. 909-914 More about this Journal
Abstract
Epithelial-mesenchymal transition (EMT) is a critical step in the acquisition of the migratory and invasive capabilities associated with metastatic competence. Cysteine-rich protein 61 (CCN1/Cyr61) has been implicated as an important mediator in the proliferation and metastasis of breast cancer. Hence, Cyr61 and associated pathways are attractive targets for therapeutic interventions directed against the EMT. In the present study, we report that baicalein significantly inhibits the expression of Cyr61 and migration and invasion of MDA-MB231 human breast cancer cells. Exposure to baicalein led to increased E-cadherin expression, possibly due to the ubiquitination of Snail and Slug, which was mediated by the Cyr61/Akt/glycogen synthase kinase $3{\beta}$ ($GSK3{\beta}$) pathway. Further analysis revealed that baicalein inhibited the expression of lysyl oxidase like-2 (LOXL-2), which is a functional collaborator of Snail and Slug, and subsequently attenuated the direct interaction between LOXL-2 and Snail or Slug, thereby enhancing $GSK3{\beta}$-dependent Snail and Slug degradation. Our findings provide new insights into the antimetastatic mechanism of baicalein and may contribute to its beneficial use in breast cancer therapies.
Keywords
Baicalein; breast cancer; Cyr61; EMT; $GSK3{\beta}$; LOXL-2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hayashi, K., Fong, K.S., Mercier, F., Boyd, C.D., Csiszar, K., and Hayashi, M., (2004). Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues. J. Mol. Histol. 35, 845-855.   DOI
2 Hou, C.H., Lin, F.L., Hou, S.M., and Liu, J.F., (2014). Cyr61 promotes epithelial-mesenchymal transition and tumour metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol. Cancer 13, 236-249.   DOI
3 Janicke, R.U., (2009). MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res. Treat. 117, 219-221.   DOI
4 Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., Dargemont, C., de Herreros, A.G., Bellacosa, A., and Larue, L., (2007). Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchymal transition. Oncogene 26, 7445-7456.   DOI
5 Kirschmann, D.A., Seftor, E.A., Fong, S.F., Nieva, D.R., Sullivan, C.M., Edwards, E.M., Sommer, P., Csiszar, K., and Hendrix, M.J., (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62, 4478-4483.
6 Kuo, H.M., Tsai, H.C., Lin, Y.L., Yang, J.S., Huang, A.C., Yang, M.D., Hsu, S.C., Chung, M.C., Gibson Wood, W., and Chung, J.G., (2009). Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells. Int. J. Oncol. 35, 717-724.
7 Lee, K.B., Byun, H.J., Park, S.H., Park, C.Y., Lee, S.H., and Rho, S.B., (2012). CYR61 controls p53 and NF-${\kappa}B$ expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett. 315, 86-95.   DOI
8 Babic, A.M., Kirreva, M.L., Kolesnikova, T.V., and Lau, L.F., (1998). CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95, 6355-6360.   DOI
9 Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., and Arteaga, C.L., (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810.   DOI
10 Barker, H.E., Chang, J., Cox, T.R., Lang, G., Bird, D., Nicolau, M., Evans, H.R., Gartland, A., and Erler, J.T., (2011). LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 71, 1561-1572.   DOI
11 Boble, B.W., and Woodgett, J.R., (2007). Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 185, 73-84.   DOI
12 Chen, C.H., Huang, L.L., Huang, C.C., Lin, C.C., Lee, Y., and Lu, F.J., (2000). Baicalein, a novel apoptotic agent for hepatoma cell lines: a potential medicine for hepatoma. Nutr. Cancer 38, 287-295.   DOI
13 Christofori, G., (2006). New signals from the invasive front. Nature 441, 444-450.   DOI
14 Chuang, J.Y., Yu, N.Y., Chiang, I.P., Lai, C.H., Lin, C.D., and Tang, C.H., (2012). Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells. J. Cell Biochem. 113, 1977-1986.   DOI
15 Lin, M.T., Zuon, C.Y., Chang, C.C., Chen, S.T., Chen, C.P., Lin, B.R., Wang, M.Y., Jeng, Y.M., Chang, K.J., Lee, P.H., et al. (2005). Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Clin. Cancer Res. 11, 5809-5820.   DOI
16 Li-Weber, M., (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 35, 57-68.   DOI
17 Ma, X., Yan, W., Dai, Z., Gao, X., Ma, Y., Xu, Q., Jiang, J., and Zhang, S., (2016). Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/${\beta}$-catenin pathway. Drug Des. Devel. Ther. 10, 1419-1441.
18 Moreno-Bueno, G., Salvador, F., Martin, A., Floristan, A., Cuevas, E.P., Santos, V., Montes, A., Morales, S., Castilla, M.A., Rojo-Sebastián, A., et al. (2011). Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol. Med. 3, 528-544.   DOI
19 Nieto, M.A., (2002). The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155-166.   DOI
20 Peinado, H., Del Carmen Iglesias-de la Cruz, M., Olmeda, D., Csiszar, K., Fong, K.S., Vega, S., Nieto, M.A., Cano, A., and Portillo, F., (2005). A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24, 3446-3458.   DOI
21 Zhou, B.P., Deng, J., Xia, W., Xu, J., Li, Y.M., Gunduz, M., and Hung, M.C., (2004). Dual regulation of Snail by GSK-3betamediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931-940.   DOI
22 Peinado, H., Moreno-Bueno, G., Hardisson, D., Perez-Gomez, E., Santos, V., Mendiola, M., de Diego, J.I., Nistal, M., Quintanilla, M., Portillo, F., et al. (2008). Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 68, 4541-4550.   DOI
23 Po, L.S., Chen, Z.Y., Tsang, D.S., and Leung, L.K., (2002). Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett. 187, 33-40.   DOI
24 Tan, T.W., Yang, W.H., Lin, Y.T., Hsu, S.F., Li, T.M., Kao, S.T., Chen, W.C., Fong, Y.C., and Tang, C.H., (2009). Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 30, 258-268.   DOI
25 Tran, T.A., Krishnamoorty, K., Cho, S.K., and Kim, S.J., (2016). Inhibitory effect of zinc sulfide nanoparticles towards breast cancer stem cell migration and invasion. J. Biomed. Nanotechnol. 12, 329-336.   DOI
26 Wang, Y., and Zhou, B.P., (2001). Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin. J. Cancer 30, 603-611.
27 Wang, L., Ling, Y., Chen, Y., Li, C.L., Feng, F., You, Q.D., Lu, N., and Guo, Q.L. (2010). Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 297, 42-48.   DOI
28 Wu, B., Li, J., Huang, D., Wang, W., Chen, Y., Liao, Y., Xiaowei, T., Hongfu, X., and Faqing, T., (2011). Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer 11, 527-35.   DOI
29 Xie, D., Nakachi, K., Wang, H., Elashoff, R., and Koeffler, H.P., (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61, 8917-8923.
30 Zhang, F., Phiel, C.J., Spece, L., Gurvich, N., and Klein, P.S., (2003). The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by betaadrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 278, 33067-33077.   DOI
31 Chung, H., Choi, H.S., Seo, E.K., Kang, D.H., and Oh, E.S., (2015). Baicalin and baicalein inhibit transforming growth factor-${\beta}1$- mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochem. Biophys. Res. Commun. 458, 707-713.   DOI
32 De Craene, B., Van Roy, F., and Berx, G., (2005). Unraveling signaling cascades for the Snail family of transcription factors. Cell. Signal. 17, 535-547.   DOI
33 Dominguez, D., Montserrat-Sentis, B., Virgos-Soler, A., Guaita, S., Grueso, J., Porta, M., Puig, I., Baulida, J., Franci, C., and Garcia de Herreros, A., (2003). Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 23, 5078-5089.   DOI
34 Fox, J.T., Sakamuru, S., Huang, R., Teneva, N., Simmons, S.O., Xia, M., Tice, R.R., Austin, C.P., Myung, K., (2012). Highthroughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc. Natl. Acad. Sci. USA 109, 5423-5428.   DOI
35 Grezeszkiewiz, T.M., Linder, V., Chen, N., Lam, S.C., and Lau, L.F., (2002). The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulate chemotaxis through integrin alpha(6)beta(1) and cell surface heparin sulfate proteoglycans. Endocrinology 143, 1441-1450.   DOI
36 Grille, S.J., Bellacosa, A., Upson, J., Klein-Szanto, A.J., van Roy, F., Lee-Kwon, W., Donowitz, M., Tsichlis, P.N., and Larue, L., (2003). The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63, 2172-2178.
37 Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P.J., Banerjee, S.K., and Banerjee, S., (2011). Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol. Cancer 10, 8-25.   DOI